Article(id=1327672684432962311, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672638123651498, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.07.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1632672000000, receivedDateStr=2021-09-27, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471434934, onlineDateStr=2026-11-12, pubDate=1657382400000, pubDateStr=2022-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471434934, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471434934, creator=13701087609, updateTime=1794471434934, updator=13701087609, issue=Issue{id=1327672638123651498, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='7', pageStart='925', pageEnd='1080', issueExtLink='null', onlineDate='null', pubDate='1657382400000', pubDateStr='2022-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471423893, creator='13701087609', updateTime=1794472192126, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327675861089760223, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672638123651498, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327675861093954528, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672638123651498, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=935, endPage=942, ext={EN=ArticleExt(id=1327672684927890184, articleId=1327672684432962311, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Progress of Liposomes for Pulmonary Drug Delivery, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

In recent years, pulmonary inhalation of drug-loaded liposomes has attracted extensive attention due to its unique release characteristics and clinical values. This review introduces the advantages of inhaled liposomes, such as reducing the irritation of drugs to lung tissue and extending the retention time of drugs in the lung. Furthermore, the commonly used liposome preparation technologies(e.g., crossflow technology) and the inhalation methods are emphatically described. Then, the marketing and clinical situations of liposome inhalation preparations are briefly introduced. It is hoped to provide literature support for the study of the liposome pulmonary inhalation route for administration.

, authors=Jie GAO, Qi ZHANG, Wenzhe WU*, authorsList=Jie GAO, Qi ZHANG, Wenzhe WU, authorCompany=null, correspAuthors=Wenzhe WU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327672685447983881, articleId=1327672684432962311, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=脂质体肺部吸入给药研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

近年来,载药脂质体肺部吸入给药因其独特的释药特点和临床意义得到广泛关注。本研究介绍了肺部吸入脂质体的优点,如减少药物对肺部的刺激性和延长药物滞留时间等。接着重点阐述了常用的脂质体制备技术(如交错流技术)和吸入方式,并对脂质体吸入制剂的上市和临床情况进行了简要介绍,以期为脂质体肺部吸入给药途径的研究提供文献支持。

, authors=高洁, 张琪, 吴闻哲*, authorsList=高洁, 张琪, 吴闻哲, authorCompany=null, correspAuthors=吴闻哲, authorNote=

高洁(1998—),女,硕士研究生,专业方向:肺部吸入给药。

, correspAuthorsNote=
吴闻哲(1973—),女,研究员,硕士生导师,从事经鼻及吸入给药研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=eG1VCx11hNHB+wQ68w40dw==, magXml=xsx4gadw3UW/sU7Kf2smdg==, pdfUrl=null, pdf=8Uc7y7AxnoOuEvM9AzQLOg==, pdfFileSize=1951911, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=4bA4jtN52P2/INgVGQIhpw==, mapNumber=null, fund=null)}, authors=[Author(id=1327672687150871310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672687368975120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687150871310, language=EN, stringName=Jie GAO, firstName=Jie, middleName=null, lastName=GAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672687473832721, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687150871310, language=CN, stringName=高洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203, bio={"content":"

高洁(1998—),女,硕士研究生,专业方向:肺部吸入给药。

"}, bioImg=null, bioContent=

高洁(1998—),女,硕士研究生,专业方向:肺部吸入给药。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672687046013706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, xref=null, ext=[AuthorCompanyExt(id=1327672687058596619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327672687075373836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203)])]), Author(id=1327672687591273235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672687708713749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687591273235, language=EN, stringName=Qi ZHANG, firstName=Qi, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672687796794134, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687591273235, language=CN, stringName=张琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672687046013706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, xref=null, ext=[AuthorCompanyExt(id=1327672687058596619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327672687075373836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203)])]), Author(id=1327672687868097304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wuwenzhe@sina.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672687964566298, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687868097304, language=EN, stringName=Wenzhe WU, firstName=Wenzhe, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672688065229595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687868097304, language=CN, stringName=吴闻哲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672687046013706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, xref=null, ext=[AuthorCompanyExt(id=1327672687058596619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327672687075373836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203)])])], keywords=[Keyword(id=1327672688170087196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=EN, orderNo=1, keyword=inhaled liposome), Keyword(id=1327672688274944797, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=EN, orderNo=2, keyword=pulmonary administration), Keyword(id=1327672688371413790, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=EN, orderNo=3, keyword=crossflow technology), Keyword(id=1327672688455299871, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=EN, orderNo=4, keyword=preparation method), Keyword(id=1327672688514020128, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=EN, orderNo=5, keyword=inhalation device), Keyword(id=1327672688614683425, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=CN, orderNo=1, keyword=吸入脂质体), Keyword(id=1327672688685986594, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=CN, orderNo=2, keyword=肺部给药), Keyword(id=1327672688774066979, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=CN, orderNo=3, keyword=交错流技术), Keyword(id=1327672688887313188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=CN, orderNo=4, keyword=制备方法), Keyword(id=1327672689000559397, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, language=CN, orderNo=5, keyword=吸入装置)], refs=[Reference(id=1327672689218663206, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=PATTON J S, BYRON P R.Inhaling medicines: delivering drugs to the body through the lungs [J].Nat Rev Drug Discov, 2007, 6(1): 67-74., articleTitle=null, refAbstract=null), Reference(id=1327672689289966375, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=HONMANE S, HAJARE A, MORE H, et al.Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy [J].J Liposome Res, 2019,29(4): 332-342., articleTitle=null, refAbstract=null), Reference(id=1327672689369658152, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=CIPOLLA D, CHAN H K.Inhaled antibiotics to treat lung infection [J].Pharm Pat Anal, 2013, 2(5): 647-663., articleTitle=null, refAbstract=null), Reference(id=1327672689428378409, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=MEHTA P P, GHOSHAL D, PAWAR A P, et al.Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance [J].J Drug Deliv Sci Technol, 2020, 56: 101509., articleTitle=null, refAbstract=null), Reference(id=1327672689508070186, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=CUESTAS M L, DEVOTO T B, TOSCANINI M A, et al.Modeling and control of drug delivery systems [M].Olney: Academic Press, 2021: 273-300., articleTitle=null, refAbstract=null), Reference(id=1327672689596150571, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=FAUVEL M, FARRUGIA C, TSAPIS N, et al.Aerosolized liposomal amphotericin B: Prediction of lung deposition, in vitro uptake and cytotoxicity [J].Int J Pharm, 2012,436(1/2): 106-110., articleTitle=null, refAbstract=null), Reference(id=1327672689663259436, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=BULBAKE U, DOPPALAPUDI S, KOMMINENI N, et al.Liposomal formulations in clinical use: an updated review[J].Pharmaceutics, 2017, 9(2): 12., articleTitle=null, refAbstract=null), Reference(id=1327672689726173997, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=PAUL S, RAO S, KOHAN R, et al.Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study [J].J Paediatr Child Health,2013, 49(10): 839-844., articleTitle=null, refAbstract=null), Reference(id=1327672691378729774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=THOMAS D A, MYERS M A, WICHERT B, et al.Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers [J].Chest, 1991, 99(5): 1268-1270., articleTitle=null, refAbstract=null), Reference(id=1327672691450032943, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=WALDREP J C, ARPPE J, JANSA K A A, et al.Experimental pulmonary delivery of cyclosporin A by liposome aerosol [J].Int J Pharm, 1998, 160(2): 239-249., articleTitle=null, refAbstract=null), Reference(id=1327672691533919024, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=WAGNER A, VORAUER-UHL K, KATINGER H.Liposomes produced in a pilot scale: production, purification and efficiency aspects [J].Eur J Pharm Biopharm, 2002,54(2): 213-219., articleTitle=null, refAbstract=null), Reference(id=1327672691601027889, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM S, KIM T, MURDANDE S.Sustained-release liposomal anesthetic compositions: US, 9205052B2 [P].2015-12-08., articleTitle=null, refAbstract=null), Reference(id=1327672691693302578, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Z, BONI L T, MILLER B S, et al.High delivery rates for lipid-based drug formulations, and methods of treatment thereof: US, 7879351B2 [P].2011-02-01., articleTitle=null, refAbstract=null), Reference(id=1327672691806548787, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=罗伯特·沃沙姆.脂质体药物配制品的制造方法:中国,112584821A [P]. 2021-03-30., articleTitle=null, refAbstract=null), Reference(id=1327672691907212084, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU X J, KONG Y, LIU Q, et al.Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy [J].Pulm Pharmacol Ther, 2019, 55: 50-61., articleTitle=null, refAbstract=null), Reference(id=1327672692016263989, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=刘晓谦,王锦玉,仝燕,等.脂质体制备技术及其研究进展[J].中国药学杂志,2011,46(14):1084-1088., articleTitle=null, refAbstract=null), Reference(id=1327672692104344374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=LI M, ZHANG T T, ZHU L F, et al.Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway [J].Int J Pharm, 2017, 528(1/2): 163-171., articleTitle=null, refAbstract=null), Reference(id=1327672692213396279, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WU Y, DUONG A, LEE L J, et al.The delivery of nanoparticles [M].London: IntechOpen, 2012: 223., articleTitle=null, refAbstract=null), Reference(id=1327672692280505144, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=DUONG A D, COLLIER M A, BACHELDER E M, et al.One step encapsulation of small molecule drugs in liposomes via electrospray-remote loading [J].Mol Pharm, 2016,13(1): 92-99., articleTitle=null, refAbstract=null), Reference(id=1327672692381168441, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=COLLIER M A, BACHELDER E M, AINSLIE K M.Electrosprayed myocet-like liposomes: an alternative to traditional liposome production [J].Pharm Res, 2017,34(2): 419-426., articleTitle=null, refAbstract=null), Reference(id=1327672692481831738, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ELHISSI A.Liposomes for pulmonary drug delivery: the role of formulation and inhalation device design [J].Curr Pharm Des, 2017, 23(3): 362-372., articleTitle=null, refAbstract=null), Reference(id=1327672692653798203, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=TIWARI D, GOLDMAN D, MALICK W A, et al.Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane(P134a), a non-CFC propellant [J].Pharm Dev Technol, 1998, 3(2): 163-174., articleTitle=null, refAbstract=null), Reference(id=1327672692754461500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=徐景娜,周学海,杨敏,等.肺部吸入制剂的研究概况[J].药物评价研究,2019,(12):2305-2308., articleTitle=null, refAbstract=null), Reference(id=1327672692817376061, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=DESHPANDE D, BLANCHARD J, SRINIVASAN S, et al.Aerosolization of lipoplexes using AERx® pulmonary delivery system [J].AAPS PharmSci, 2015, 4(3): E13., articleTitle=null, refAbstract=null), Reference(id=1327672692913845054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Insmed Inc.Arikayce®(amikacin liposome inhalation suspension), for oral inhalation use: US prescribing information [EB/OL].[2021-09-25].https://www.arikayce.com/. Accessed 5 Nov 2020., articleTitle=null, refAbstract=null), Reference(id=1327672693010314047, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MISRA A, JINTURKAR K, PATEL D, et al.Recent advances in liposomal dry powder formulations: preparation and evaluation [J].Expert Opin Drug Deliv, 2009, 6(1):71-89., articleTitle=null, refAbstract=null), Reference(id=1327672693085811520, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=CHOUGULE M, PADHI B, MISRA A.Development of spray dried liposomal dry powder inhaler of dapsone [J].AAPS Pharmscitech, 2008, 9(1): 47-53., articleTitle=null, refAbstract=null), Reference(id=1327672693157114689, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=GANDHI M, PANDYA T, GANDHI R, et al.Inhalable liposomal dry powder of gemcitabine-HCl: formulation, in vitro characterization and in vivo studies [J].Int J Pharm,2015, 496(2): 886-895., articleTitle=null, refAbstract=null), Reference(id=1327672693215834946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=YE T T, YU J Q, LUO Q H, et al.Inhalable clarithromycin liposomal dry powders using ultrasonic spray freeze drying[J].Powder Technol, 2017, 305: 63-70., articleTitle=null, refAbstract=null), Reference(id=1327672693274555203, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LEUNG K K M, BRIDGES P A, TAYLOR K M G.The stability of liposomes to ultrasonic nebulization [J].Int J Pharm, 1996, 145(1/2): 95-102., articleTitle=null, refAbstract=null), Reference(id=1327672693354246980, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=CIPOLLA D, GONDA I, CHAN H K.Liposomal formulations for inhalation [J].Ther Deliv, 2013, 4(8):1047-1072., articleTitle=null, refAbstract=null), Reference(id=1327672693412967237, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=FINLAY W H, WONG J P.Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin [J].Int J Pharm, 1998, 167(1/2): 121-127., articleTitle=null, refAbstract=null), Reference(id=1327672693496853318, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=US FDA.Insmed Ltd. Amikacin liposome inhalation suspension: antimicrobial drugs advisory committee briefing materials [EB/OL].[2021-09-25].http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM615723.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672693572350791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=ELHISSI A M A, FAIZI M, NAJI W F, et al.Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures [J].Int J Pharm, 2007, 334(1/2): 62-70., articleTitle=null, refAbstract=null), Reference(id=1327672693643653960, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=PONKSHE P, FENG S, TAN C.Inhalable liposomes for treating lung diseases: clinical development and challenges[J].Biomed Mater, 2021, 16(5): 054101., articleTitle=null, refAbstract=null), Reference(id=1327672693714957129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=SHIRLEY M.Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease [J].Drugs, 2019, 79(5): 555-562., articleTitle=null, refAbstract=null), Reference(id=1327672693807231818, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=BROWN-ELLIOTT B A, IAKHIAEVA E, GRIFFITH D E, et al.In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates [J].J Clin Microbiol, 2013, 51(10): 3389-3394., articleTitle=null, refAbstract=null), Reference(id=1327672693907895115, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=BROWN-ELLIOTT B A, NASH K A, WALLACE R J Jr.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria [J].Clin Microbiol Rev, 2012, 25(3): 545-582., articleTitle=null, refAbstract=null), Reference(id=1327672693979198284, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=WEERS J, METZHEISER B, TAYLOR G, et al.A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers [J].J Aerosol Med Pulm Drug Deliv, 2009,22(2): 131-138., articleTitle=null, refAbstract=null), Reference(id=1327672694050501453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=GRIFFITH D E, EAGLE G, THOMSON R, et al.Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex(CONVERT): a prospective, open-label, randomized study [J].Am J Respir Crit Care Med, 2018, 198(12):1559-1569., articleTitle=null, refAbstract=null), Reference(id=1327672694146970446, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=US FDA.Arikayce®(amikacin liposome inhalation suspension): US prescribing information [EB/OL].[2021-09-25].http://www.accessdata.fda.gov/drugsatfdadocs/label/2018/207356s000lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672695837274959, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=U.S. National Library of Medicine.Evaluation of a therapeutic strategy including nebulised liposomal amphotericin B (Ambisome®) in maintenance treatment of allergic Bronchopulmonary Aspergillosis (cystic fibrosis excluded) (NEBULAMB) [EB/OL].[2021-09-25].https://clinicaltrials.gov/ct2/show/NCT02273661?term=NCT02273661&rank=1., articleTitle=null, refAbstract=null), Reference(id=1327672695929549648, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=U.S. National Library of Medicine.Value of amphotericin B inhalation for prophylaxis of invasive pulmonary aspergillosis after renal transplantation [EB/OL].[2021-09-25].https://clinicaltrials.gov/ct2/show/NCT00986713?term=NCT00986713&rank=1., articleTitle=null, refAbstract=null), Reference(id=1327672695992464209, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=RIJNDERS B J, CORNELISSEN J, SLOBBE L, et al.Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial [J].Clin Infect Dis, 2008, 46(9): 1401-1408., articleTitle=null, refAbstract=null), Reference(id=1327672696059573074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=CIPOLLA D, BLANCHARD J, GONDA I.Development of liposomal ciprofloxacin to treat lung infections [J].Pharmaceutics, 2016, 8(1): 6., articleTitle=null, refAbstract=null), Reference(id=1327672696135070547, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=BRUINENBERG P.Inhaled liposomal ciprofloxacin: once a day management of respiratory infections [C]// Respiratory drug delivery.River Grove: Davis Healthcare International Publishing, 2010., articleTitle=null, refAbstract=null), Reference(id=1327672696206373716, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=YAO X, PANICHPISAL K, KURTZMAN N, et al.Cisplatin nephrotoxicity: a review [J].Am J Med Sci, 2007, 334(2):115-124., articleTitle=null, refAbstract=null), Reference(id=1327672696286065493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=KOSMIDIS C, SAPALIDIS K, ZAROGOULIDIS P, et al.Inhaled cisplatin for NSCLC: facts and results [J].Int J Mol Sci, 2019, 20(8): 2005., articleTitle=null, refAbstract=null), Reference(id=1327672696348980054, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=WITTGEN B P H, KUNST P W A, VAN DER BORN K, et al.PhaseⅠstudy of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung [J].Clin Cancer Res, 2007, 13(8): 2414-2421., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327672687046013706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, xref=null, ext=[AuthorCompanyExt(id=1327672687058596619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327672687075373836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.07.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.07.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.07.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.07.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1657382400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
脂质体肺部吸入给药研究进展
高洁 , 张琪 , 吴闻哲 *
中国医药工业杂志 | 综述 2022,53(7): 935-942
收起
收藏切换
中国医药工业杂志 |综述 2022 , 53 (7) : 935 -942
脂质体肺部吸入给药研究进展
全屏
[Author(id=1327672687150871310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672687368975120, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687150871310, language=EN, stringName=Jie GAO, firstName=Jie, middleName=null, lastName=GAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672687473832721, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687150871310, language=CN, stringName=高洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203, bio={"content":"

高洁(1998—),女,硕士研究生,专业方向:肺部吸入给药。

"}, bioImg=null, bioContent=

高洁(1998—),女,硕士研究生,专业方向:肺部吸入给药。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672687046013706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, xref=null, ext=[AuthorCompanyExt(id=1327672687058596619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327672687075373836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203)])]), Author(id=1327672687591273235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672687708713749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687591273235, language=EN, stringName=Qi ZHANG, firstName=Qi, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672687796794134, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687591273235, language=CN, stringName=张琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672687046013706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, xref=null, ext=[AuthorCompanyExt(id=1327672687058596619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327672687075373836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203)])]), Author(id=1327672687868097304, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wuwenzhe@sina.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672687964566298, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687868097304, language=EN, stringName=Wenzhe WU, firstName=Wenzhe, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672688065229595, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, authorId=1327672687868097304, language=CN, stringName=吴闻哲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672687046013706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, xref=null, ext=[AuthorCompanyExt(id=1327672687058596619, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327672687075373836, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327672684432962311, companyId=1327672687046013706, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院药物制剂国家工程研究中心,上海 201203)])])]
高洁, 张琪, 吴闻哲*
作者信息
  • 中国医药工业研究总院药物制剂国家工程研究中心,上海 201203
通讯作者:
吴闻哲(1973—),女,研究员,硕士生导师,从事经鼻及吸入给药研究。E-mail:
作者简介:

高洁(1998—),女,硕士研究生,专业方向:肺部吸入给药。

Progress of Liposomes for Pulmonary Drug Delivery
Jie GAO, Qi ZHANG, Wenzhe WU*
Affiliations
  • National Pharmaceutical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203
出版时间: 2022-07-10 doi: 10.16522/j.cnki.cjph.2022.07.002
文章导航
收藏切换

近年来,载药脂质体肺部吸入给药因其独特的释药特点和临床意义得到广泛关注。本研究介绍了肺部吸入脂质体的优点,如减少药物对肺部的刺激性和延长药物滞留时间等。接着重点阐述了常用的脂质体制备技术(如交错流技术)和吸入方式,并对脂质体吸入制剂的上市和临床情况进行了简要介绍,以期为脂质体肺部吸入给药途径的研究提供文献支持。

吸入脂质体  /  肺部给药  /  交错流技术  /  制备方法  /  吸入装置

In recent years, pulmonary inhalation of drug-loaded liposomes has attracted extensive attention due to its unique release characteristics and clinical values. This review introduces the advantages of inhaled liposomes, such as reducing the irritation of drugs to lung tissue and extending the retention time of drugs in the lung. Furthermore, the commonly used liposome preparation technologies(e.g., crossflow technology) and the inhalation methods are emphatically described. Then, the marketing and clinical situations of liposome inhalation preparations are briefly introduced. It is hoped to provide literature support for the study of the liposome pulmonary inhalation route for administration.

inhaled liposome  /  pulmonary administration  /  crossflow technology  /  preparation method  /  inhalation device
高洁, 张琪, 吴闻哲. 脂质体肺部吸入给药研究进展. 中国医药工业杂志, 2022 , 53 (7) : 935 -942 . DOI: 10.16522/j.cnki.cjph.2022.07.002
Jie GAO, Qi ZHANG, Wenzhe WU. Progress of Liposomes for Pulmonary Drug Delivery[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (7) : 935 -942 . DOI: 10.16522/j.cnki.cjph.2022.07.002

参考文献 引证文献
排序方式:
[1]
PATTON J S, BYRON P R.Inhaling medicines: delivering drugs to the body through the lungs [J].Nat Rev Drug Discov, 2007, 6(1): 67-74.
[2]
HONMANE S, HAJARE A, MORE H, et al.Lung delivery of nanoliposomal salbutamol sulfate dry powder inhalation for facilitated asthma therapy [J].J Liposome Res, 2019,29(4): 332-342.
[3]
CIPOLLA D, CHAN H K.Inhaled antibiotics to treat lung infection [J].Pharm Pat Anal, 2013, 2(5): 647-663.
[4]
MEHTA P P, GHOSHAL D, PAWAR A P, et al.Recent advances in inhalable liposomes for treatment of pulmonary diseases: concept to clinical stance [J].J Drug Deliv Sci Technol, 2020, 56: 101509.
[5]
CUESTAS M L, DEVOTO T B, TOSCANINI M A, et al.Modeling and control of drug delivery systems [M].Olney: Academic Press, 2021: 273-300.
[6]
FAUVEL M, FARRUGIA C, TSAPIS N, et al.Aerosolized liposomal amphotericin B: Prediction of lung deposition, in vitro uptake and cytotoxicity [J].Int J Pharm, 2012,436(1/2): 106-110.
[7]
BULBAKE U, DOPPALAPUDI S, KOMMINENI N, et al.Liposomal formulations in clinical use: an updated review[J].Pharmaceutics, 2017, 9(2): 12.
[8]
PAUL S, RAO S, KOHAN R, et al.Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study [J].J Paediatr Child Health,2013, 49(10): 839-844.
[9]
THOMAS D A, MYERS M A, WICHERT B, et al.Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers [J].Chest, 1991, 99(5): 1268-1270.
[10]
WALDREP J C, ARPPE J, JANSA K A A, et al.Experimental pulmonary delivery of cyclosporin A by liposome aerosol [J].Int J Pharm, 1998, 160(2): 239-249.
[11]
WAGNER A, VORAUER-UHL K, KATINGER H.Liposomes produced in a pilot scale: production, purification and efficiency aspects [J].Eur J Pharm Biopharm, 2002,54(2): 213-219.
[12]
KIM S, KIM T, MURDANDE S.Sustained-release liposomal anesthetic compositions: US, 9205052B2 [P].2015-12-08.
[13]
LI Z, BONI L T, MILLER B S, et al.High delivery rates for lipid-based drug formulations, and methods of treatment thereof: US, 7879351B2 [P].2011-02-01.
[14]
罗伯特·沃沙姆.脂质体药物配制品的制造方法:中国,112584821A [P]. 2021-03-30.
[15]
ZHU X J, KONG Y, LIU Q, et al.Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy [J].Pulm Pharmacol Ther, 2019, 55: 50-61.
[16]
刘晓谦,王锦玉,仝燕,等.脂质体制备技术及其研究进展[J].中国药学杂志,2011,46(14):1084-1088.
[17]
LI M, ZHANG T T, ZHU L F, et al.Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway [J].Int J Pharm, 2017, 528(1/2): 163-171.
[18]
WU Y, DUONG A, LEE L J, et al.The delivery of nanoparticles [M].London: IntechOpen, 2012: 223.
[19]
DUONG A D, COLLIER M A, BACHELDER E M, et al.One step encapsulation of small molecule drugs in liposomes via electrospray-remote loading [J].Mol Pharm, 2016,13(1): 92-99.
[20]
COLLIER M A, BACHELDER E M, AINSLIE K M.Electrosprayed myocet-like liposomes: an alternative to traditional liposome production [J].Pharm Res, 2017,34(2): 419-426.
[21]
ELHISSI A.Liposomes for pulmonary drug delivery: the role of formulation and inhalation device design [J].Curr Pharm Des, 2017, 23(3): 362-372.
[22]
TIWARI D, GOLDMAN D, MALICK W A, et al.Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane(P134a), a non-CFC propellant [J].Pharm Dev Technol, 1998, 3(2): 163-174.
[23]
徐景娜,周学海,杨敏,等.肺部吸入制剂的研究概况[J].药物评价研究,2019,(12):2305-2308.
[24]
DESHPANDE D, BLANCHARD J, SRINIVASAN S, et al.Aerosolization of lipoplexes using AERx® pulmonary delivery system [J].AAPS PharmSci, 2015, 4(3): E13.
[25]
Insmed Inc.Arikayce®(amikacin liposome inhalation suspension), for oral inhalation use: US prescribing information [EB/OL].[2021-09-25].https://www.arikayce.com/. Accessed 5 Nov 2020.
[26]
MISRA A, JINTURKAR K, PATEL D, et al.Recent advances in liposomal dry powder formulations: preparation and evaluation [J].Expert Opin Drug Deliv, 2009, 6(1):71-89.
[27]
CHOUGULE M, PADHI B, MISRA A.Development of spray dried liposomal dry powder inhaler of dapsone [J].AAPS Pharmscitech, 2008, 9(1): 47-53.
[28]
GANDHI M, PANDYA T, GANDHI R, et al.Inhalable liposomal dry powder of gemcitabine-HCl: formulation, in vitro characterization and in vivo studies [J].Int J Pharm,2015, 496(2): 886-895.
[29]
YE T T, YU J Q, LUO Q H, et al.Inhalable clarithromycin liposomal dry powders using ultrasonic spray freeze drying[J].Powder Technol, 2017, 305: 63-70.
[30]
LEUNG K K M, BRIDGES P A, TAYLOR K M G.The stability of liposomes to ultrasonic nebulization [J].Int J Pharm, 1996, 145(1/2): 95-102.
[31]
CIPOLLA D, GONDA I, CHAN H K.Liposomal formulations for inhalation [J].Ther Deliv, 2013, 4(8):1047-1072.
[32]
FINLAY W H, WONG J P.Regional lung deposition of nebulized liposome-encapsulated ciprofloxacin [J].Int J Pharm, 1998, 167(1/2): 121-127.
[33]
US FDA.Insmed Ltd. Amikacin liposome inhalation suspension: antimicrobial drugs advisory committee briefing materials [EB/OL].[2021-09-25].http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM615723.pdf.
[34]
ELHISSI A M A, FAIZI M, NAJI W F, et al.Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures [J].Int J Pharm, 2007, 334(1/2): 62-70.
[35]
PONKSHE P, FENG S, TAN C.Inhalable liposomes for treating lung diseases: clinical development and challenges[J].Biomed Mater, 2021, 16(5): 054101.
[36]
SHIRLEY M.Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease [J].Drugs, 2019, 79(5): 555-562.
[37]
BROWN-ELLIOTT B A, IAKHIAEVA E, GRIFFITH D E, et al.In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates [J].J Clin Microbiol, 2013, 51(10): 3389-3394.
[38]
BROWN-ELLIOTT B A, NASH K A, WALLACE R J Jr.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria [J].Clin Microbiol Rev, 2012, 25(3): 545-582.
[39]
WEERS J, METZHEISER B, TAYLOR G, et al.A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers [J].J Aerosol Med Pulm Drug Deliv, 2009,22(2): 131-138.
[40]
GRIFFITH D E, EAGLE G, THOMSON R, et al.Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex(CONVERT): a prospective, open-label, randomized study [J].Am J Respir Crit Care Med, 2018, 198(12):1559-1569.
[41]
US FDA.Arikayce®(amikacin liposome inhalation suspension): US prescribing information [EB/OL].[2021-09-25].http://www.accessdata.fda.gov/drugsatfdadocs/label/2018/207356s000lbl.pdf.
[42]
U.S. National Library of Medicine.Evaluation of a therapeutic strategy including nebulised liposomal amphotericin B (Ambisome®) in maintenance treatment of allergic Bronchopulmonary Aspergillosis (cystic fibrosis excluded) (NEBULAMB) [EB/OL].[2021-09-25].https://clinicaltrials.gov/ct2/show/NCT02273661?term=NCT02273661&rank=1.
[43]
U.S. National Library of Medicine.Value of amphotericin B inhalation for prophylaxis of invasive pulmonary aspergillosis after renal transplantation [EB/OL].[2021-09-25].https://clinicaltrials.gov/ct2/show/NCT00986713?term=NCT00986713&rank=1.
[44]
RIJNDERS B J, CORNELISSEN J, SLOBBE L, et al.Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial [J].Clin Infect Dis, 2008, 46(9): 1401-1408.
[45]
CIPOLLA D, BLANCHARD J, GONDA I.Development of liposomal ciprofloxacin to treat lung infections [J].Pharmaceutics, 2016, 8(1): 6.
[46]
BRUINENBERG P.Inhaled liposomal ciprofloxacin: once a day management of respiratory infections [C]// Respiratory drug delivery.River Grove: Davis Healthcare International Publishing, 2010.
[47]
YAO X, PANICHPISAL K, KURTZMAN N, et al.Cisplatin nephrotoxicity: a review [J].Am J Med Sci, 2007, 334(2):115-124.
[48]
KOSMIDIS C, SAPALIDIS K, ZAROGOULIDIS P, et al.Inhaled cisplatin for NSCLC: facts and results [J].Int J Mol Sci, 2019, 20(8): 2005.
[49]
WITTGEN B P H, KUNST P W A, VAN DER BORN K, et al.PhaseⅠstudy of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung [J].Clin Cancer Res, 2007, 13(8): 2414-2421.
2022年第53卷第7期
78
13
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.07.002
  • 接收时间:2021-09-27
  • 首发时间:2026-11-12
  • 出版时间:2022-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-09-27
基金
作者信息
    中国医药工业研究总院药物制剂国家工程研究中心,上海 201203

通讯作者:

吴闻哲(1973—),女,研究员,硕士生导师,从事经鼻及吸入给药研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.07.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏